Product Image

Women's Vitality

Ancient Nutrition
4.8
★ ★ ★ ★ ★
(91 ratings)
Vitamin K 200 mcg
Iodine 290 mcg
Iron 6 mg
Product Image
Score46
A few useful vitamins cannot compensate for a huge proprietary blend, unquantified probiotic, six-capsule serving, and premium cost.
How scoring works
Quantity:180 Capsule(s) • (30 servings)
Goals:
Cardiovascular Support
Bone Health
Heart Health

Score 46

A few useful vitamins cannot compensate for a huge proprietary blend, unquantified probiotic, six-capsule serving, and premium cost.
How scoring works
$50.96($1.69 per serving)
Daily Vita
$ 50.96
Pure Formulas
$ 50.96
Vitacost
$ 56.07
iHerb
$ 50.96
Report prices

Analysis

Vitamin D3, MK-7 vitamin K2, vitamin B12, iron, and iodine cover several nutrients relevant to women's health. The disclosed amounts are easy to identify, although cyanocobalamin is a conventional B12 form.

The large women's vitality blend does not reveal its component doses in the supplied data. That prevents meaningful evaluation of its expected effects, allergens, and medicine interactions, while the probiotic is listed by weight rather than viable count.

Six capsules per serving and a high daily cost create a demanding routine. The formula depends heavily on an opaque blend, so the disclosed vitamins alone do not justify the burden for most users.

Who is it for
  • Adults specifically seeking the listed women's vitality blend
  • Users willing to accept limited ingredient-level disclosure
Best for
  • Vitamin D3 and K2 coverage
  • Iodine support
  • Women with a confirmed need for modest iron

Pros

  • Uses vitamin D3
  • Includes MK-7 vitamin K2
  • Discloses iron and iodine
  • Broad proprietary blend amount is stated

Cons

  • Blend ingredients and doses are hidden
  • Probiotic potency is not given in viable count
  • Six capsules per serving
  • Very high serving cost

Warnings

  • The proprietary blend prevents reliable screening for allergies and medicine interactions.
  • Vitamin K2 can oppose warfarin.
  • Iron and iodine should match individual needs, particularly with thyroid conditions or other supplements.

Nutrient quality

59 Moderate impact

MK-7 and vitamin D3 provide a useful core. Unspecified mineral forms and a large hidden blend sharply limit dose and safety confidence.

Ingredient transparency

40 Lower impact

Several core nutrient amounts are stated. The large hidden blend, vague forms, and absent excipient details create major disclosure gaps.

Customer satisfaction

63 Moderate impact

The supplied average rating is strong. Specific feedback is absent, so complaint consistency and purpose fit remain uncertain.

Value for money

23 Situational impact

The MK-7 and vitamin D3 core adds some value. High serving cost, a multi-capsule serving, and hidden doses make the formula uncompetitive.

Report analysis

Goals

Cardiovascular Support
Impact
Highest effect
B+ Goal FitA Strength of SupportC- CoverageA+ Formula Quality
Vitamin K · 200 mcgVitamin D · 25 mcgVitamin B12 · 24 mcg

Two hundred micrograms of vitamin K2 as MK-7 paired with vitamin D3 provides strong calcium-management support for arterial health. The formula does not address lipids, vascular tone, cardiac energy, or rhythm minerals.

The MK-7 subtype and amount are clear, while the dry capsule lacks fat-intake guidance. Vitamin K2 can counteract warfarin and related vitamin-K-antagonist medicines, so users of those drugs need prescriber-guided intake consistency.

Study evidence
Vitamin K Supportive 40 studies
Impact
High effect
B Goal FitB- Strength of SupportC CoverageB+ Formula Quality
Vitamin K · 200 mcgVitamin D · 25 mcg

Vitamin K provides a clear and meaningful foundation for bone support. The main relevant amounts appear substantial enough to contribute in practice.

Coverage is concentrated on vitamin-guided mineral handling. The focused design leaves other major bone pathways uncovered.

Study evidence
Vitamin K Supportive 78 studies
Heart Health
Impact
High effect
B- Goal FitA- Strength of SupportC- CoverageD+ Formula Quality
Vitamin K · 200 mcgVitamin B12 · 24 mcgVitamin D · 25 mcg

MK-7 vitamin K2 and vitamin D3 form a strong pairing for calcium handling and arterial flexibility. The disclosed MK-7 amount is substantial and uses the preferred long-lasting subtype.

Most of the large vitality blend is undisclosed, so its dose quality and cardiovascular relevance cannot be assessed. Vitamin K2 can counteract warfarin and related vitamin K antagonists, making clinician-guided use important for people taking those medicines.

Study evidence
Vitamin K Mixed 62 studies
General Health
Impact
Moderate effect
B- Goal FitC Strength of SupportC- CoverageD+ Formula Quality
Vitamin B12 · 24 mcgVitamin D · 25 mcgVitamin K · 200 mcg

Vitamin D3 and 200 mcg vitamin K2 provide a strong, coherent bone-support pairing, while iodine, iron, and B12 add selected foundational nutrients. The MK-7 form is well suited to sustained vitamin K activity.

A 3.7 g proprietary vitality blend hides most of the formula, and the six-capsule serving is cumbersome. Vitamin K2 can counteract warfarin and similar vitamin K antagonists, so users of those medicines need consistent intake and medical guidance.

Study evidence
Vitamin K Supportive 34 studies
Energy
Impact
Moderate effect
C+ Goal FitD+ Strength of SupportC CoverageD+ Formula Quality
Iodine · 290 mcgVitamin D · 25 mcgVitamin B12 · 24 mcgIron · 6 mg

Iodine, vitamin B12, iron, and a large vitality blend provide several possible routes to metabolic and stress-related support. The iodine amount is substantial and directly relevant to thyroid hormone production.

Key mineral forms and the contents of the large blend are not disclosed, making dose quality hard to judge. Iron and vitamin B12 fall below focused thresholds, while the six-capsule serving adds burden.

Study evidence
Iodine Adverse 3 studies
Iron Supportive 74 studies
Anti-Aging
Impact
Moderate effect
D+ Goal FitC+ Strength of SupportD CoverageD Formula Quality
Vitamin B12 · 24 mcgVitamin K · 200 mcgVitamin D · 25 mcg

Vitamin D3 and a clinically aligned 200 mcg MK-7 amount support age-relevant bone and arterial calcium management. Vitamin B12 and the broader blend may add nutritional and vitality support.

The 3.7 g vitality blend does not disclose its individual amounts, so most of the formula cannot be evaluated for meaningful longevity potency. People using warfarin should keep vitamin K intake consistent with their anticoagulation plan.

Study evidence
Vitamin D Supportive 50 studies
Vitamin K Supportive 27 studies

Ingredients

IngredientAmount per serving
Vitamin D3 (Saccharomyces cerevisae)
25 mcg
Vitamin K2 (Menaquinone-7)
200 mcg
Vitamin B12 (Cyanocobalamin)
24 mcg
Iron
6 mg
Iodine
290 mcg
Women's Vitality Blend
3.7 Gram(s)
Bacillus coagulans
14 mg
Adults 18–50
Report overview
C+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyD+ Value

The formula uses MK-7, the preferred long-lasting vitamin K2 subtype. The 200 mcg MK-7 serving lies within the preferred clinical range. The dry capsule lacks fat-intake guidance, while the higher serving cost is partly justified by a clinical MK-7 dose and added vitamin D3.

Iodine · 290 mcg OverallScore60
D- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value

Missing source identity leaves both bioavailability and marine-purity risk uncertain. The 290 mcg amount sits near the upper end of the preferred daily range and remains below the adult upper limit. High cost and an undisclosed iodine source weaken value despite an effective dose.

Iron · 6 mg OverallScore39
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyF Value

Missing iron-form disclosure prevents a meaningful judgment of absorption and digestive tolerance. The elemental amount is below the preferred effective range. The capsule format is practical but has no stated slow-release or liquid advantage. Requiring several units creates a substantial adherence burden. Folate or vitamin B12 is present, but vitamin C does not reach the absorption-support threshold. Serving cost provides poor iron-specific value.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Joint association of serum 25-hydroxyvitamin D concentration and body mass index on the acceleration of clinical biomarker-based biological aging.
    Pan Z; Zeng J; Chen Z; Chen S; Yang J; Li H; Wang S; Wang J; Li N; Gong Y; Liu M; Li C · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Cohort study389,217 participantsAnti-Aging forVitamin D
  2. Serum 25-Hydroxyvitamin D Levels as an Aging Marker: Strong Associations With Age and All-Cause Mortality Independent From Telomere Length, Epigenetic Age Acceleration, and 8-Isoprostane Levels.
    Schöttker B; Hagen L; Zhang Y; Gào X; Holleczek B; Gao X; Brenner H · The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Cohort study9,940 participantsAnti-Aging forVitamin D
  3. Sex-specific associations of serum 25-hydroxyvitamin D concentrations with incident sarcopenia in older adults: A 2-year follow-up study.
    Song S; Lim JY; Kim M; Won CW; Park HY · The journal of nutrition, health & aging · 2025
    Cohort study1,292 participantsAnti-Aging forVitamin D
  4. Vitamin D deficit is associated with accelerated brain aging in the general population.
    Terock J; Bonk S; Frenzel S; Wittfeld K; Garvert L; Hosten N; Nauck M; Völzke H; Van der Auwera S; Grabe HJ · Psychiatry research. Neuroimaging · 2022
    Cross-sectional study1,865 participantsAnti-Aging forVitamin D
  5. Vitamin D intake is associated with dementia risk in the Washington Heights-Inwood Columbia Aging Project (WHICAP).
    Zhao C; Tsapanou A; Manly J; Schupf N; Brickman AM; Gu Y · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Cohort study1,759 participantsAnti-Aging forVitamin D
  6. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledAnti-Aging General Health forVitamin K
  7. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsAnti-Aging forVitamin K
  8. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsAnti-Aging forVitamin K
  9. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsAnti-Aging forVitamin K
  10. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsAnti-Aging forVitamin K
  11. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  12. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  13. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  14. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  15. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  16. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  17. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  18. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  19. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  20. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  21. Association of radioactive iodine treatment with survivorship symptoms and primary care utilisation in women of reproductive age with thyroid cancer: a retrospective cohort study.
    Devanarayan P; Hartman M; Partin M · Family medicine and community health · 2026
    Cohort study10,882 participantsEnergy forIodine
  22. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
    Hughes DT; Reyes-Gastelum D; Kovatch KJ; Hamilton AS; Ward KC; Haymart MR · Surgery · 2020
    Cohort study2,584 participantsEnergy forIodine
  23. Health-Related Quality of Life in Differentiated Thyroid Cancer Survivors: A Cross-Sectional Study From Turkey.
    Gültekin A; Kahraman MY; Şengöz T; Şimşek FS · Head & neck · 2026
    Cross-sectional study202 participantsEnergy forIodine
  24. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT · Transfusion · 2010
    Randomized trial477 participantsEnergy forIron
  25. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
    Macher S; Herster C; Holter M; Moritz M; Matzhold EM; Stojakovic T; Pieber TR; Schlenke P; Drexler C; Amrein K · Nutrients · 2021
    Randomized trial176 participantsEnergy forIron
  26. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J; FER-ASAP investigators · Journal of perinatal medicine · 2018
    Randomized trial252 participantsEnergy forIron
  27. Effect of iron therapy on fatigue symptoms in non-anaemic iron deficient women of reproductive age- A Randomized Controlled Trial.
    Sultana N; Bajwa FA; Sikandar MZ; Haider MM; Majeed T · JPMA. The Journal of the Pakistan Medical Association · 2026
    Randomized trial164 participantsEnergy forIron
  28. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage.
    Holm C; Thomsen LL; Langhoff-Roos J · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2019
    Randomized trial85 participantsEnergy forIron
  29. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsGeneral Health forVitamin K
  30. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsGeneral Health forVitamin K
  31. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledGeneral Health forVitamin K
  32. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsGeneral Health forVitamin K
  33. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K